tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Steinberg, 117 are a BUY (83.57%), 22 are a HOLD (15.71%), 1 are a SELL (0.71%).
Analyst David Steinberg, currently employed carries an average stock price target met ratio of 65.48% that have a potential upside of 27.47% achieved within 212 days. Previously, David Steinberg worked at JEFFERIES.
David Steinberg’s has documented 265 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PRGO, Perrigo Company PLC at 24-Sep-2024.
Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for SUPN (SUPERNUS PHARMACEUTICALS) at 6/15/2020. The price target of $24 was fulfilled within 1 day with a profit of $0.93 (4.03%) receiving and performance score of 40.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$8
$4.02 (101.01%)
13 days ago
(19-Nov-2024)
0/3 (0%)
$3.83 (91.85%)
Hold
$7
$3.02 (75.88%)
13 days ago
(19-Nov-2024)
1/5 (20%)
$2.83 (67.87%)
315
Hold
$13
$9.02 (226.63%)
$2
14 days ago
(18-Nov-2024)
1/5 (20%)
$10.46 (411.81%)
354
Hold
2 months 15 days ago
(17-Sep-2024)
0/5 (0%)
$34.34 (396.54%)
Hold
$1
$-2.98 (-74.87%)
$2
11 months 14 days ago
(18-Dec-2023)
2/4 (50%)
$0.06 (6.38%)
178
Which stock is David Steinberg is most bullish on?
What Year was the first public recommendation made by David Steinberg?
